Type 2 & other diabetes

Impact of type 2 diabetes on the relationship between chronic kidney disease and cardiovascular outcomes in heart failure across ejection fraction: observational study from the Swedish heart failure and the Swedish National diabetes registries

Cardiovasc DiabetolPublished Registry-based cohort study

Authors' conclusion

In a contemporary HF cohort, decreased kidney function was associated with a progressively higher risk of HHF/CV death, and T2D was not a risk modifier. Renal protection should therefore be implemented in HF regardless of T2D.

Study context

Population
Heart failure (HF) patients in the Swedish Heart Failure Registry, January 2017 to December 2021; 8,053 (22%) with T2D; 53%, 25%, 22% HF with reduced, mildly-reduced and preserved ejection fraction (EF)
Participants
36,597 patients
Exposure
eGFR categories in HF patients with vs without T2D
  • eGFR ≥ 60n = 23,562
  • eGFR 45-59n = 7,122
  • eGFR 30-44n = 4,477
  • eGFR < 30n = 1,436
Outcome
Composite of:
  • Time to first HF hospitalization (HHF)
  • CV death
Methodological detailsobservational, linkage of Swedish Heart Failure Registry and National Diabetes Registry, multivariable Cox regression with interaction testing, subgroup analysis by EF
  • Observational
  • Linkage of Swedish Heart Failure Registry and National Diabetes Registry
  • Multivariable Cox regression with interaction testing
  • Subgroup analysis by EF

Main finding

As reported in the abstract

HHF or CV death by eGFR category, according to T2D
Consistent across EF, except HFpEF with eGFR < 30 ml/min/1.73 m²: association smaller in T2D than non-T2D
p-interaction < 0.01

Observational data: associations, not effects.

Secondary outcomes

Major adverse CV events (MACE), cardiovascular (CV) death and all-cause mortality by eGFR category

Risks higher for lower eGFR categories, with lower hazards in T2D group
P for interaction < 0.01

Baseline characteristics by T2D

Across eGFR, patients with vs without T2D were younger, more often male, with higher CV comorbidity and more frequent use of cardio-renal drugs
Across EF categories, T2D patients had higher prevalence of chronic kidney disease (CKD)

Original publication

Impact of type 2 diabetes on the relationship between chronic kidney disease and cardiovascular outcomes in heart failure across ejection fraction: observational study from the Swedish heart failure and the Swedish National diabetes registries. Cardiovasc Diabetol. Published 1 December 2025. doi:10.1186/s12933-025-02998-w

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.